News and Media

Latest News Release
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health and SurgiCount Medical Sign Exclusive Agreement for Bar-coded Lap Sponges, OR Towels and Gauze
11/20/2006
New System Focuses on Improving Patient Safety in the Operating Room

DUBLIN, Ohio, Nov. 20, 2006 — Cardinal Health, Inc., the leading provider of products and services supporting the health-care industry, today announced it has signed an exclusive national agreement with SurgiCount Medical Inc., a wholly-owned subsidiary of Patient Safety Technologies, Inc., (AMEX: PST) to make available its patented Safety Sponge™ System to hospitals and surgery centers across the country. The bar-code system helps operating room staff keep track of items commonly used in surgery.  Financial terms of the three-year agreement were not disclosed.

 

Cardinal Health will package SurgiCount’s Lap sponges, gauze sponges and OR towels in its Presource® surgical kits and trays.  SurgiCount Medical received FDA 510(k) clearance to market and sell its Safety-Sponge in March 2006. The SurgiCount Safety-Sponge System is the only computer-assisted system for counting sponges with FDA clearance.

 

'Ensuring patient safety is a key initiative for hospitals today and the prevention of retained objects during surgery is a critical element of that mission, said Brik Eyre, president of Cardinal Health’s Presource business. “This agreement demonstrates our commitment to helping our customers deliver safe, high-quality patient care.”



“The Safety-Sponge System applies 21st century technology to sponge counting to advance patient safety,” said Bill Adams, CEO of SurgiCount Medical. “ The intuitive nature of the system’s software and the clear and informative screens enable OR staff to be constantly aware of their sponge count, as well as providing printing, archiving and electronic downloading opportunities for documentation for the perioperative nurse.”



In its recommended practices for sponge, sharp and instrument counts, the Association of periOperative Registered Nurses (AORN) advises that all sponges, sharps, instruments, and materials introduced during a surgical procedure, including sterile towels used to pack viscera, should be counted for all surgical procedures. According to AORN, a primary goal of counts is to prevent foreign bodies from being retained in patients; therefore, all items introduced into patients must be accounted for.



The SurgiCount Safety-Sponge System works much like a grocery store check-out counter. Every lap sponge, OR towel or gauze sponge is thermally fused with a unique, patented bar code. Items are swiped under a scanning counter (i.e. computer assisted counting) before the procedure to obtain a count. At the end of surgery, the labels are swiped to verify the number of items. The sponge counter provides audio and visual cues, has a read-rate error of one in 240 million scans, and has the ability to print, archive and download reports at the end of each procedure.



About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an $81 billion, global company serving the health-care industry with a broad portfolio of products and services.  Through its diverse offerings, Cardinal Health delivers health-care solutions that help customers reduce their costs, improve safety and productivity, and deliver better care to patients. The company manufactures, packages and distributes pharmaceuticals and medical supplies, offers a range of clinical services and develops automation products that improve the management and delivery of supplies and medication for hospitals, physician offices and pharmacies. Ranked No. 19 on the Fortune 500, Cardinal Health employs more than 55,000 people on six continents. More information about the company may be found at www.cardinalhealth.com.

 

Except for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended.  These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied.  The most significant of these uncertainties are described in Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those reports, and include (but are not limited to) the following: competitive pressures in its various lines of business; the loss of one or more key customer or supplier relationships or changes to the terms of those relationships; changes in the distribution patterns or reimbursement rates for health-care products and/or services; the results, consequences, effects or timing of any inquiry or investigation by or settlement discussions with any regulatory authority or any legal and administrative proceedings, including shareholder litigation; difficulties in opening new facilities or fully utilizing existing capacity; the costs, difficulties and uncertainties related to the integration of acquired businesses; and general economic and market conditions.  Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement.

More Company News
04/22/2024

Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed. The company reaffirmed its...

04/02/2024

The Consumer Health Logistics Center will be located in Central Ohio and serve as a centralized hub for distribution of consumer health products COLUMBUS, Ohio, April 2, 2024 /PRNewswire/ --...

03/26/2024

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2, prior to the opening of trading on the New York Stock Exchange. The company will...

03/15/2024

Cardinal Health (NYSE: CAH) today announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions...

View all company news »